This vial contains Novolin® 70/30 which is a mixture of 70% NPH, human insulin isophane suspension (recombinant DNA origin) and 30% Regular, human insulin injection (recombinant DNA origin) USP. The concentration of this product is 100 units of insulin per milliliter. It is a cloudy or milky suspension of human insulin with protamine and zinc. The insulin substance (the cloudy material) settles at the bottom of the vial, therefore, the vial must be gently agitated or rotated so that the contents are uniformly mixed before a dose is withdrawn. Novolin® 70/30 has an intermediate duration of action. The effect of Novolin® 70/30 begins approximately 1/2 hour after injection. The effect is maximal between 2 and approximately 12 hours. The full duration of action may last up to 24 hours after injection.
Sign up to receive exclusive email-only savings and information.